blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4023246

EP4023246 - SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  03.06.2022
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  05.03.2021
Most recent event   Tooltip31.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
San-Ei Gen F.F.I., INC.
1-1-11, Sanwa-cho
Toyonaka-shi, Osaka 561-8588 / JP
[2022/27]
Inventor(s)01 / NAKAO, Tomohiro
c/o SAN-EI GEN F.F.I., INC., 1-1-11, Sanwa-cho
Toyonaka-shi, Osaka 561-8588 / JP
02 / IMAI, Yuki
c/o SAN-EI GEN F.F.I., INC., 1-1-11, Sanwa-cho
Toyonaka-shi, Osaka 561-8588 / JP
 [2022/27]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstraße 3
81675 München / DE
[2022/27]
Application number, filing date20858780.828.08.2020
[2022/27]
WO2020JP32765
Priority number, dateJP2019015912630.08.2019         Original published format: JP 2019159126
JP2020002282113.02.2020         Original published format: JP 2020022821
[2022/27]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021040027
Date:04.03.2021
Language:JA
[2021/09]
Type: A1 Application with search report 
No.:EP4023246
Date:06.07.2022
Language:EN
[2022/27]
Search report(s)International search report - published on:JP04.03.2021
(Supplementary) European search report - dispatched on:EP06.09.2023
ClassificationIPC:A61K45/00, A61P3/02, A61P43/00, A61Q11/00, A61Q19/00, A61Q5/00, A61K9/14, A61K9/16, A61K9/20, A61K9/48, A23L29/206, A23L29/231, A23L29/238, A23L29/25, A23L29/256, A23L29/262, A23L29/269, A23L33/10, A23L33/105, A23L33/125
[2022/27]
CPC:
A61P3/02 (EP); A61K9/1652 (KR,US); A61K8/9789 (CN);
A23L29/00 (KR); A23L29/206 (CN); A23L29/212 (CN);
A23L29/231 (CN); A23L29/238 (CN); A23L29/25 (CN);
A23L29/256 (CN); A23L29/262 (CN); A23L29/27 (CN);
A23L29/271 (CN); A23L29/272 (CN); A23L29/274 (CN);
A23L29/30 (CN); A23L29/35 (CN); A23L33/10 (CN);
A23L33/105 (EP,CN,US); A23L33/15 (EP,CN); A23L33/155 (CN);
A61K31/015 (CN); A61K31/047 (CN); A61K31/05 (EP,CN);
A61K31/07 (CN); A61K31/12 (EP,CN,KR,US); A61K31/122 (EP);
A61K31/352 (EP,CN); A61K31/355 (CN); A61K31/357 (EP,CN);
A61K31/36 (EP); A61K31/59 (CN); A61K31/7048 (CN);
A61K45/06 (EP); A61K47/36 (CN); A61K47/38 (CN,KR);
A61K47/40 (CN); A61K8/0216 (EP); A61K8/0245 (US);
A61K8/31 (CN); A61K8/347 (CN); A61K8/35 (CN,US);
A61K8/498 (CN); A61K8/602 (CN); A61K8/67 (CN);
A61K8/671 (CN); A61K8/678 (CN); A61K8/73 (EP,CN);
A61K8/731 (EP,CN,KR); A61K8/732 (CN); A61K8/738 (CN);
A61K9/146 (EP); A61K9/1682 (US); A61P43/00 (EP);
A61Q11/00 (CN,KR); A61Q19/00 (EP,KR); G01N23/2055 (CN);
G01N23/207 (CN); A23V2002/00 (KR); A23V2250/51 (KR);
A23V2250/51086 (KR); A61K2800/10 (EP); A61K2800/805 (EP) (-)
C-Set:
A61K31/05, A61K2300/00 (EP);
A61K31/122, A61K2300/00 (EP);
A61K31/12, A61K2300/00 (EP);
A61K31/352, A61K2300/00 (EP);
A61K31/357, A61K2300/00 (EP);
A61K31/36, A61K2300/00 (EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/27]
TitleGerman:FESTE ZUSAMMENSETZUNG MIT AMORPHEM SCHLECHT WASSERLÖSLICHEM MATERIAL UND VERFAHREN ZU DEREN HERSTELLUNG[2022/27]
English:SOLID COMPOSITION CONTAINING AMORPHOUS, POORLY WATER-SOLUBLE MATERIAL, AND METHOD FOR PRODUCING SAME[2022/27]
French:COMPOSITION SOLIDE CONTENANT UNE MATIÈRE AMORPHE, PEU SOLUBLE DANS L'EAU, ET SON PROCÉDÉ DE PRODUCTION[2022/27]
Entry into regional phase18.03.2022Translation filed 
18.03.2022National basic fee paid 
18.03.2022Search fee paid 
18.03.2022Designation fee(s) paid 
18.03.2022Examination fee paid 
Examination procedure18.03.2022Examination requested  [2022/27]
03.04.2024Amendment by applicant (claims and/or description)
03.04.2024Date on which the examining division has become responsible
Fees paidRenewal fee
26.08.2022Renewal fee patent year 03
22.08.2023Renewal fee patent year 04
30.08.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO9116899  (SUMITOMO PHARMA [JP], et al) [X] 1-8 * claim 1 * [Y] 1-15;
 [XY]WO2010075663  (UNIV JIANGSU [CN], et al) [X] 1-8 * claim 2 *[Y] 1-15;
 [XY]WO2014154793  (FRESENIUS KABI DE GMBH [DE]) [X] 1-8 * page 1, paragraph 1 * * example 5 * [Y] 1-15;
 [XY]US2015024060  (MADHAVI DODDABELE L [US], et al) [X] 1-8 * example 3 * [Y] 1-15;
 [XY]WO2016010093  (THERAVALUES CORP [JP]) [X] 1-4,7,8,12-15 * examples 1-7; claims 1-5 * * page 2, paragraph 7 * * Test example 1;; figures 1-3 * [Y] 1-15;
 [X]WO2016108351  (LOTTE FINE CHEMICAL CO LTD [KR]) [X] 1-8 * examples 12-14; table 1 * * page 1, paragraph 1 *;
 [X]CN106619535  (UNIV SHANXI MEDICAL) [X] 1-8,12-15 * examples 6,10 *
International search[XYA]JPH05139974  (FUJISAWA PHARMACEUTICAL CO) [X] 1, 4-11 [Y] 12, 14-15 [A] 2-3, 13;
 [XY]JPH05262642  [X] 1, 4-11 * ,1, 3 1, 3 * [Y] 2-15;
 [XY]WO0195941  (NIPPON SHINYAKU CO LTD [JP], et al) [X] 1, 4-11 * ,1, 1 * [Y] 2-15;
 [Y]JP2007002243  (UNIV OSAKA, et al) [Y] 12-15* [0 0 3 1 ] *;
 [Y]WO2015174475  (THERAVALUES CORP [JP], et al) [Y] 2-15 * [0 0 1 0 ] *;
 [Y]WO2016021707  (CHUGAI PHARMACEUTICAL CO LTD [JP]) [Y] 12-15 * [0008]-[0009] *;
 [Y]WO2016198576  (INDENA SPA [IT]) [Y] 2-15 * 2 16-3 8 *;
 [Y]WO2019160146  (THERAVALUES CORP [JP]) [Y] 2-15 * [0 0 0 7] *
by applicant   - Japanese Pharmacopoeia
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.